🇺🇸 Fluotestin in United States

FDA authorised Fluotestin on 15 October 1956

Marketing authorisations

FDA — authorised 15 October 1956

  • Status: approved

FDA — authorised 15 October 1956

  • Application: NDA010611
  • Marketing authorisation holder: PHARMACIA AND UPJOHN
  • Local brand name: HALOTESTIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 6 July 1981

  • Application: ANDA087196
  • Marketing authorisation holder: VALEANT PHARM INTL
  • Local brand name: ANDROID-F
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 5 May 1983

  • Application: ANDA088221
  • Marketing authorisation holder: VALEANT PHARM INTL
  • Local brand name: FLUOXYMESTERONE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 21 October 1983

  • Application: ANDA088342
  • Marketing authorisation holder: UPSHER SMITH LABS
  • Local brand name: FLUOXYMESTERONE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088265
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: FLUOXYMESTERONE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088309
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: FLUOXYMESTERONE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: NDA011359
  • Marketing authorisation holder: BRISTOL MYERS SQUIBB
  • Local brand name: ORA-TESTRYL
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088260
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: FLUOXYMESTERONE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Fluotestin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Fluotestin approved in United States?

Yes. FDA authorised it on 15 October 1956; FDA authorised it on 15 October 1956; FDA authorised it on 6 July 1981.

Who is the marketing authorisation holder for Fluotestin in United States?

Marketing authorisation holder not available in our data.